News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago

146last 24h

877last 7d

147● bullish (7d)

96● bearish (7d)

214publishers

All Macro211 Earnings108 M&A126 Regulatory21 Product21 Analyst17

✕ clear all filtersticker: ARDXsentiment: bullishSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Zacks52d agobullish

Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates

Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +18.56% and +11.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ARDX

Insider Monkey117d agobullish

Should You Buy Ardelyx (ARDX)?

We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot. Ardelyx Inc. (NASDAQ:ARDX) ranks #9 (see Claude Stock Portfolio: Top 5 Stocks to Buy According to AI Chatbot). Number of Hedge Funds: 30 Biotech company Ardelyx Inc. (NASDAQ:ARDX) is one of the recent additions in the Claude portfolio. Anthropic’s […]

ARDX

Zacks147d agobullish

Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of -15.39% and +3.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

ARDX